- Illustrations
- Specialized Illustrations
- Cellular and molecular processes
- A Nerve Ending's Internal Structure
A Nerve Ending's Internal Structure
Internal structure of a nerve ending, containing a complex organization of synaptic vesicles and the terminal membrane.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Within the terminal bouton of an axon, the animation tracks the internal organization of a nerve ending as it abuts its target membrane at a presumptive synaptic cleft. Synaptic vesicles cluster in the presynaptic cytoplasm near an active zone, while the terminal (presynaptic) membrane defines the interface with the postsynaptic surface. As the sequence advances, vesicles move toward the membrane, dock, and cycle through fusion and retrieval, emphasizing the polarized, distal specializations of the neuron at its farthest functional end. Synaptic transmission is where neurophysiology becomes concrete: vesicle docking and exocytosis explain millisecond signaling, quantal release, and the pharmacology of many anesthetics and neurotoxins. Botulinum toxin, for example, prevents synaptic vesicle fusion by cleaving SNARE proteins, producing flaccid paralysis at cholinergic nerve terminals, while Lambert-Eaton myasthenic syndrome reduces presynaptic calcium entry and lowers acetylcholine release. Animation clarifies timing and sequence in a way a static diagram cannot, letting viewers connect vesicle pools, membrane fusion, and recycling to changes in synaptic strength and fatigue. Use this clip in neuroanatomy and neuroscience courses when introducing chemical synapses, vesicle pools (readily releasable versus reserve), and axon terminal ultrastructure, or in pharmacology teaching when mapping drug targets to presynaptic steps. It also fits cleanly into publisher content on synaptic physiology, neuromuscular junction disorders, and mechanisms of toxin-mediated paralysis. Anatomical accuracy verified by SciePro's Medical Advisory Board.